n a regulatory filing, CalciMedica disclosed that its director Robert Wilson bought 54K shares of common stock on August 23rd in a total transaction size of $201K.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CALC:
- CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
- CalciMedica reports $19.1M in cash, equivalents
- CalciMedica reports Q2 EPS (36c), consensus (53c)
- CalciMedica price target raised to $20 from $14 at Oppenheimer
- CalciMedica enrolls first patient in trial of Auxora in acute kidney injury